<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2019//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_190101.dtd">
<PubmedArticleSet>
  <PubmedArticle>
    <MedlineCitation Status="MEDLINE" Owner="NLM">
      <PMID Version="1">33908804</PMID>
      <DateCompleted>
        <Year>2022</Year>
        <Month>02</Month>
        <Day>03</Day>
      </DateCompleted>
      <DateRevised>
        <Year>2022</Year>
        <Month>02</Month>
        <Day>03</Day>
      </DateRevised>
      <Article PubModel="Print-Electronic">
        <Journal>
          <ISSN IssnType="Electronic">1615-7109</ISSN>
          <JournalIssue CitedMedium="Internet">
            <Volume>25</Volume>
            <Issue>6</Issue>
            <PubDate>
              <Year>2021</Year>
              <Season>Nov-Dec</Season>
            </PubDate>
          </JournalIssue>
          <Title>Journal of cutaneous medicine and surgery</Title>
          <ISOAbbreviation>J Cutan Med Surg</ISOAbbreviation>
        </Journal>
        <ArticleTitle>Coexistence of Hidradenitis Suppurativa and Steatocystoma Multiplex: Is It a New Variant of Hidradenitis Suppurativa?</ArticleTitle>
        <Pagination>
          <StartPage>586</StartPage>
          <EndPage>590</EndPage>
          <MedlinePgn>586-590</MedlinePgn>
        </Pagination>
        <ELocationID EIdType="doi" ValidYN="Y">10.1177/12034754211010145</ELocationID>
        <Abstract>
          <AbstractText>Hidradenitis suppurativa and steatocystoma multiplex may coexist in the same patient. The overlap of these 2 conditions could be suggestive of an unrecognized defect in follicular proliferation mutual in the pathogenesis of both conditions. Here we present 5 patients with both hidradenitis suppurativa and steatocystoma multiplex. Recognizing the overlap between these 2 conditions is important for accurate diagnosis, management, and identification of potential surgical candidates, as well as future basic science research.</AbstractText>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Fletcher</LastName>
            <ForeName>Joshua</ForeName>
            <Initials>J</Initials>
            <Identifier Source="ORCID">0000-0002-1501-8401</Identifier>
            <AffiliationInfo>
              <Affiliation>Faculty of Medicine, University of Toronto, 1 King's College Circle, Medical Sciences Bldg, Toronto, Canada.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Posso-De Los Rios</LastName>
            <ForeName>Claudia</ForeName>
            <Initials>C</Initials>
            <AffiliationInfo>
              <Affiliation>7938 Division of Dermatology, Department of Medicine, University of Toronto, Toronto, Canada.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Jambrosic</LastName>
            <ForeName>Jadranka</ForeName>
            <Initials>J</Initials>
            <AffiliationInfo>
              <Affiliation>Kingsway Dermatology, Toronto, Canada.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Alavi</LastName>
            <ForeName>Afsaneh</ForeName>
            <Initials>A</Initials>
            <Identifier Source="ORCID">0000-0003-1171-4917</Identifier>
            <AffiliationInfo>
              <Affiliation>12366 Department of Dermatology, Mayo Clinic, Rochester, MN, USA.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D002363">Case Reports</PublicationType>
          <PublicationType UI="D016428">Journal Article</PublicationType>
        </PublicationTypeList>
        <ArticleDate DateType="Electronic">
          <Year>2021</Year>
          <Month>04</Month>
          <Day>28</Day>
        </ArticleDate>
      </Article>
      <MedlineJournalInfo>
        <MedlineTA>J Cutan Med Surg</MedlineTA>
        <NlmUniqueID>9614685</NlmUniqueID>
        <ISSNLinking>1203-4754</ISSNLinking>
      </MedlineJournalInfo>
      <CitationSubset>IM</CitationSubset>
      <MeshHeadingList>
        <MeshHeading>
          <DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D003937" MajorTopicYN="N">Diagnosis, Differential</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D017497" MajorTopicYN="N">Hidradenitis Suppurativa</DescriptorName>
          <QualifierName UI="Q000150" MajorTopicYN="Y">complications</QualifierName>
          <QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName>
          <QualifierName UI="Q000628" MajorTopicYN="N">therapy</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D062685" MajorTopicYN="N">Steatocystoma Multiplex</DescriptorName>
          <QualifierName UI="Q000150" MajorTopicYN="Y">complications</QualifierName>
          <QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName>
          <QualifierName UI="Q000628" MajorTopicYN="N">therapy</QualifierName>
        </MeshHeading>
      </MeshHeadingList>
      <KeywordList Owner="NOTNLM">
        <Keyword MajorTopicYN="N">dermatology</Keyword>
        <Keyword MajorTopicYN="N">inflammatory dermatoses</Keyword>
      </KeywordList>
      <CoiStatement><b>Declaration of Conflicting Interests:</b> The author(s) declared the following potential conflicts of interest with respect
to the research, authorship, and/or publication of this article: AA has acted as
a consultant, advisor, and/or received research funding from Abbvie, Galderma,
Janssen, LEO Pharma, Novartis, Sanofi Aventis, Valeant, Boehringer-Ingelheim,
DSBiopharma, Eli Lilly, Glenmark, Incyte, Ilkos, Merck Serono, Pfizer,
Regeneron, Roche, Xenon, Kymea, Kyowa and Xoma.</CoiStatement>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="pubmed">
          <Year>2021</Year>
          <Month>4</Month>
          <Day>29</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="medline">
          <Year>2022</Year>
          <Month>2</Month>
          <Day>4</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="entrez">
          <Year>2021</Year>
          <Month>4</Month>
          <Day>28</Day>
          <Hour>12</Hour>
          <Minute>11</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>ppublish</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">33908804</ArticleId>
        <ArticleId IdType="pmc">PMC8637365</ArticleId>
        <ArticleId IdType="doi">10.1177/12034754211010145</ArticleId>
      </ArticleIdList>
      <ReferenceList>
        <Reference>
          <Citation>
Zouboulis CC., Desai N., Emtestam L.
et al.. European S1 guideline for the treatment of
hidradenitis suppurativa/acne inversa. J Eur Acad
Dermatol Venereol.
2015;29(4):619-644.10.1111/jdv.12966
</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1111/jdv.12966</ArticleId>
            <ArticleId IdType="pubmed">25640693</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Gasparic J., Theut Riis P., Jemec GB. Recognizing syndromic hidradenitis suppurativa:
a review of the literature. J Eur Acad Dermatol
Venereol.
2017;31(11):1809-1816.10.1111/jdv.14464
</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1111/jdv.14464</ArticleId>
            <ArticleId IdType="pubmed">28696038</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Hollmig T., Menter A. Familial coincidence of hidradenitis suppurativa
and steatocystoma multiplex. Clin Exp
Dermatol.
2010;35(4):e151-e152.10.1111/j.1365-2230.2009.03742.x
</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1111/j.1365-2230.2009.03742.x</ArticleId>
            <ArticleId IdType="pubmed">19886955</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Santana CN., Pereira DD., Lisboa AP., Leal JM., Obadia DL., Silva RS. Steatocystoma multiplex suppurativa: case report
of a rare condition. An Bras Dermatol.
2016;91(5 suppl
1):51-53.10.1590/abd1806-4841.20164539
</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1590/abd1806-4841.20164539</ArticleId>
            <ArticleId IdType="pmc">PMC5324992</ArticleId>
            <ArticleId IdType="pubmed">28300893</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Zussino M., Nazzaro G., Moltrasio C., Marzano AV., Marzano AV. Coexistence of steatocystoma multiplex and
hidradenitis suppurativa: assessment of this unique association by means of
ultrasonography and color Doppler. Skin Res
Technol.
2019;25(6):1-4.10.1111/srt.12751
</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1111/srt.12751</ArticleId>
            <ArticleId IdType="pubmed">31353757</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Alotaibi L., Alsaif M., Alhumidi A., Turkmani M., Alsaif F. Steatocystoma multiplex suppurativa: a case with
unusual giant cysts over the scalp and neck. Case
Rep Dermatol.
2019;11(1):71-76.10.1159/000498882
</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1159/000498882</ArticleId>
            <ArticleId IdType="pmc">PMC6465725</ArticleId>
            <ArticleId IdType="pubmed">31011316</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Adams B., Shwayder T. Steatocystoma multiplex
suppurativum. Int J Dermatol.
2008;47(11):1155-1156.10.1111/j.1365-4632.2008.03698.x
</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1111/j.1365-4632.2008.03698.x</ArticleId>
            <ArticleId IdType="pubmed">18986448</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Apaydin R., Bilen N., Bayramgürler D., Başdaş F., Harova G., Dökmeci S. Steatocystoma multiplex suppurativum: oral
isotretinoin treatment combined with cryotherapy.
Australas J Dermatol.
2000;41(2):98-100.10.1046/j.1440-0960.2000.00403.x
</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1046/j.1440-0960.2000.00403.x</ArticleId>
            <ArticleId IdType="pubmed">10812703</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Monteiro A., Rato M., Tavares E. Inherited steatocystoma multiplex
suppurativa. J Am Acad Dermatol.
2018;6550.
10.1016/j.jaad.2018.05.689
</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.jaad.2018.05.689</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Scheinfeld N. Diseases associated with hidranitis suppurativa:
Part 2 of a series on hidradenitis. Dermatol Online
J. 2013;19(6):
</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">24011308</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
McDonald RM., Reed WB. Natal teeth and steatocystoma multiplex
complicated by hidradenitis suppurativa. A new syndrome.
Arch Dermatol.
1976;112(8):1132-1139.10.1001/archderm.1976.01630320038010
</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1001/archderm.1976.01630320038010</ArticleId>
            <ArticleId IdType="pubmed">988984</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Pavlovsky M., Sarig O., Eskin-Schwartz M.
et al.. A phenotype combining hidradenitis
suppurativa with Dowling-Degos disease caused by a founder mutation in
PSENEN
. Br J Dermatol.
2018;178(2):502-508.10.1111/bjd.16000
</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1111/bjd.16000</ArticleId>
            <ArticleId IdType="pubmed">28922471</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
McGarth J. Concurrent hidradenitis suppurativa and
dowling–degos disease taken down a ‘Notch’. Br J
Dermatol. 2018;74:10.1111/bjd.16068
</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1111/bjd.16068</ArticleId>
            <ArticleId IdType="pubmed">29441533</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Covello S., Smith F., Sillevis Smitt J.
et al.. Keratin 17 mutations cause either
steatocystoma multiplex or pachyonychia congenita type 2.
Br J Dermatol.
1998;1:475-480.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">9767294</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Agut-Busquet E., de Gabriel J., Pibernat M., Gonzalez A., Moreno J. Dowling-Degos syndrome and hidradenitis
suppurativa: An uncommon association with linked pathogenesis? Report of
nien cases and review of the literature. J Am Acad
Dermatol. 2017;4929
10.1016/j.jaad.2017.04.416
</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.jaad.2017.04.416</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Bedlow AJ., Mortimer PS., George S., Road B. Dowling-Degos disease associated with
hidradenitis suppurativa. Clin Exp
Dermatol.
1996;21(4):305-306.10.1111/j.1365-2230.1996.tb00103.x
</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1111/j.1365-2230.1996.tb00103.x</ArticleId>
            <ArticleId IdType="pubmed">8959907</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Loo WJ., Rytina E., Todd PM. Hidradenitis suppurativa, Dowling-Degos and
multiple epidermal cysts: a new follicular occlusion triad.
Clin Exp Dermatol.
2004;29(6):622-624.10.1111/j.1365-2230.2004.01631.x
</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1111/j.1365-2230.2004.01631.x</ArticleId>
            <ArticleId IdType="pubmed">15550138</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Cho S., Chang S-E., Choi J-H., Sung K-J., Moon K-C., Koh J-K. Clinical and histologic features of 64 cases of
steatocystoma multiplex. J Dermatol.
2002;29(3):152-156.10.1111/j.1346-8138.2002.tb00238.x
</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1111/j.1346-8138.2002.tb00238.x</ArticleId>
            <ArticleId IdType="pubmed">11990250</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Goeteyn M., Geerts ML., Kint A., De Weert J., De WJ. The Bazex-Dupré-Christol
syndrome. Arch Dermatol.
1994;130(3):337-342.10.1001/archderm.1994.01690030069011
</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1001/archderm.1994.01690030069011</ArticleId>
            <ArticleId IdType="pubmed">8129412</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Kim YC., Davis MD., Schanbacher CF., Su WP., disease D-D. Dowling-Degos disease (reticulate pigmented
anomaly of the flexures): a clinical and histopathologic study of 6
cases. J Am Acad Dermatol.
1999;40(3):462-467.10.1016/S0190-9622(99)70498-6
</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/S0190-9622(99)70498-6</ArticleId>
            <ArticleId IdType="pubmed">10071319</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Garg A., Strunk A., Midura M., Papagermanos V., Pomerantz H. Prevalence of hidradenitis suppurativa among
patients with Down syndrome: a population-based cross-sectional
analysis. Br J Dermatol.
2018;178(3):697-703.10.1111/bjd.15770
</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1111/bjd.15770</ArticleId>
            <ArticleId IdType="pubmed">28662304</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Caceres-Rios H., Tamayo-Sanchez L., Duran-Mckinster C., de la Luz Orozco M., Ruiz-Maldonado R., Keratitis R-MR. Keratitis, ichthyosis, and deafness (kid
syndrome): review of the literature and proposal of a new
terminology. Pediatr Dermatol.
1996;13(2):105-113.10.1111/j.1525-1470.1996.tb01414.x
</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1111/j.1525-1470.1996.tb01414.x</ArticleId>
            <ArticleId IdType="pubmed">9122065</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Vural S., Gundogdu M., Kundakci N., Ruzicka T. Familial Mediterranean fever patients with
hidradenitis suppurativa. Int J Dermatol.
2017;56(6):660-663.10.1111/ijd.13503
</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1111/ijd.13503</ArticleId>
            <ArticleId IdType="pubmed">28194777</ArticleId>
          </ArticleIdList>
        </Reference>
      </ReferenceList>
    </PubmedData>
  </PubmedArticle>
</PubmedArticleSet>
